An Overview of Viking Therapeutics's Earnings
An Overview of Viking Therapeutics's Earnings
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.Viking Therapeutics (NASDAQ:VKTX) is preparing to release its quarterly earnings on Wednesday, 2024-10-23. Here's a brief overview of what investors should keep in mind before the announcement.
viking therapeutics（納斯達克:VKTX）正準備在2024年10月23日星期三發佈其季度收益。以下是投資者在公佈之前應該記住的要點。
Analysts expect Viking Therapeutics to report an earnings per share (EPS) of $-0.25.
分析師預計 Viking Therapeutics 將報告每股收益 (EPS) 爲 $-0.25。
Anticipation surrounds Viking Therapeutics's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.
市場關注 Viking Therapeutics 的公告，投資者希望聽到超出預期的消息，並獲得下一季度的積極指引。
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.
新投資者應該了解，儘管收益表現很重要，但市場反應往往受到指引的推動。
Earnings Track Record
歷史業績追蹤
Last quarter the company beat EPS by $0.07, which was followed by a 28.31% increase in the share price the next day.
上個季度公司的每股收益超出 $0.07，隨後第二天股價上漲 28.31%。
Here's a look at Viking Therapeutics's past performance and the resulting price change:
讓我們回顧一下 Viking Therapeutics 的過往表現和由此導致的股價變化：
| Quarter | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| EPS Estimate | -0.27 | -0.28 | -0.26 | -0.22 |
| EPS Actual | -0.20 | -0.26 | -0.25 | -0.23 |
| Price Change % | 28.000000000000004% | 6.0% | 18.0% | -9.0% |
| 季度 | 2024年第二季度 | 2024年第一季度 ("Q1 2024") | 2023年第四季度 | 2023年第三季度 |
|---|---|---|---|---|
| 每股收益預估值 | -0.27 | -0.28 | -0.26 | -0.22 |
| 每股收益實際值 | -0.20 | -0.26 | -0.25 | -0.23 |
| 價格變更% | 28.000000000000004% | 6.0% | 18.0% | -9.0% |
Market Performance of Viking Therapeutics's Stock
viking therapeutics股票的市場表現
Shares of Viking Therapeutics were trading at $64.34 as of October 21. Over the last 52-week period, shares are up 484.35%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.
截至10月21日，Viking Therapeutics的股價爲64.34美元。在過去的52週中，股價上漲了484.35%。考慮到這些回報通常是積極的，長期股東可能對這一業績表示看好。
To track all earnings releases for Viking Therapeutics visit their earnings calendar on our site.
要追蹤viking therapeutics的所有業績發佈，請訪問我們網站上的業績日曆。
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文由Benzinga的自動化內容引擎生成並由編輯審查。
譯文內容由第三人軟體翻譯。
